ARTICLE | Company News
Novartis to build biologics facility in Singapore
November 1, 2012 1:34 AM UTC
Novartis AG (NYSE:NVS; SIX:NOVN) plans to build a new facility in the Tuas area of Singapore to support clinical and commercial production of biologics, including mAbs for cancer, autoimmune and respi...